For a woman with consecutive normal Pap smears and HPV testing negative for all high‑risk types over the past two years, what is the recommended cervical cancer screening interval?

Recommended Screening Interval: Continue Every 5 Years

For a woman with two consecutive years of negative HPV testing (all high-risk types) and normal Pap smears, the recommended screening interval is every 5 years using either primary HPV testing (preferred) or co-testing (HPV + cytology). 1

Key Recommendation

The 2020 American Cancer Society guidelines clearly establish that primary HPV testing every 5 years is the preferred screening strategy for women aged 25-65 years, with co-testing every 5 years or cytology alone every 3 years as acceptable alternatives 1. Your patient's negative results over 2 years indicate she is at very low risk and should continue routine screening at the recommended 5-year interval, not more frequently.

Why This Interval Is Safe

• HPV-negative status provides exceptional reassurance: Women who test negative for high-risk HPV have an extremely low 5-year cumulative incidence of cervical cancer—approximately 3.2 per 100,000 women when both HPV and cytology are negative 2

• HPV testing is more sensitive than cytology alone: A single negative HPV test is sufficient to provide reassurance against cervical cancer over 5 years, making it superior to cytology-based screening 2

• The USPSTF (2018) and multiple other guidelines consistently support 5-year intervals for HPV-based screening in women aged 30-65 years 3

Critical Pitfall to Avoid

Do not screen more frequently than recommended. The guidelines explicitly state that "individuals should not be screened more frequently than at the recommended interval for the test used and should not be screened annually at any age by any method" 1. Annual or biennial screening in low-risk women increases false positives, unnecessary procedures, and patient anxiety without improving outcomes.

Screening Options Going Forward

For women aged 30-65 years, acceptable strategies include 1, 3:

1. Primary HPV testing every 5 years (preferred)
2. Co-testing (HPV + cytology) every 5 years (acceptable)
3. Cytology alone every 3 years (acceptable where HPV testing unavailable)

The preference for HPV-based testing reflects its superior sensitivity for detecting precancerous lesions and its ability to identify women at highest risk, particularly for adenocarcinoma 2.

When to Stop Screening

Screening can be discontinued after age 65 if the patient has adequate negative prior screening, defined as either 1:

• 2 consecutive negative primary HPV tests, OR
• 2 negative co-tests, OR
• 3 negative cytology tests within the past 10 years

The most recent test must have occurred within the past 3-5 years depending on the test type used.